Home intravenous antibiotic treatments in cystic fibrosis units of Madrid;Tratamiento antibiótico intravenoso domiciliario en las unidades de fibrosis quística de la Comunidad de Madrid

Medicina Clinica

Volumn 122, Issue 17, 2004, Pages 648-652

  Girón, Rosa María ^a   Martínez, Ana ^a   Máiz, Luís ^b   Salcedo, Antonio ^c   Beltrán, Blanca ^c   Martínez, María Teresa ^d   Antelo, Carmen ^c   Barrio, Isabel ^e   Prados, Concha ^e   Cabanillas, Juan ^e   Ancochea, Julio ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL INFANTIL UNIVERSITARIO NIÑO JESÚS   (Spain)

^d HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^e HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

Author keywords

Cystic fibrosis; Home treatment; Intravenous antibiotic

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFTAZIDIME; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; TOBRAMYCIN;

ADOLESCENT; ADULT; AGE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL INFECTION; CANNULA; CHILD; CYSTIC FIBROSIS; EMERGENCY WARD; FEMALE; FORCED EXPIRATORY VOLUME; GENDER; HOME CARE; HOSPITAL; HOSPITAL PATIENT; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PANCREAS FUNCTION; PRIMARY MEDICAL CARE; PSEUDOMONAS AERUGINOSA; RESPIRATORY SYSTEM; SKIN MANIFESTATION; SPAIN; VASCULAR ACCESS;

EID: 2942511486     PISSN: 00257753     EISSN: None     Source Type: Journal    
DOI: 10.1157/13061385     Document Type: Article

References (23)

1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1-9.
2. Cystic Fibrosis Foundation. Patient Registry 2001 Annual Report. Bethesda: Cystic Fibrosis Foundation, 2002.
3. Elborn JS, Prescott RJ, Stack BH, Goodchild MC, Bates J, Pantin C, et al. Elective versus symptomatic antibiotic treatment in cystic fibrosis patients with chronic Pseudomonas infection of the lungs. Thorax 2002;55:355-8.
4. Salcedo A, Girón RM, Beltrán B, Martínez A, Máiz L, Suárez L. Conferencia de consenso. Tratamiento antibiótico intravenoso domiciliario en la fibrosis quística. Arch Bronconeumol 2003; 39:469-75.
5. Maiz L, Baranda F, Coll R, Prados C, Vendrell M, Escribano A, et al. Normativa del diagnóstico y tratamiento de la afección respiratoria en la fibrosis quística. Arch Bronconeumol 2001;37: 316-24.
6. Buck C, Holl R, Kohne E, Wofl A. Silastic catheters for home antibiotics therapy in patients with cystic fibrosis. Eur J Pediatr 1997;156:209-11.
7. Bramwell EC, Halpin DM, Duncan-Skingle F, Hodson ME, Geddes DM. Home treatment of patients with cystic fibrosis using the «Intermate»: the first year's experience. J Adv Nurs 1995; 22:1063-67.
8. Ramsey B, Pepe M, Quan J, Otto K, Montgomery A, Williams-Waren J, et al. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. N Engl J Med 1999;340:23-30.
9. Rucker RW, Harrison GM. Outpatient intravenous medications in the management of the cystic fibrosis. Pediatr 1974;54:358-60.
10. Bosworth DG, Nielson DW. Effectiveness of home versus hospital care in the routine treatment of cystic fibrosis. Pediatr Pulmonol 1997; 24:42-7.
11. Marco T, Asensio O, Bosque M, De Gracia J, Serra C. Home intravenous antibiotics for cystic fibrosis. Cochrane Database Syst Rev 2000; CD001917.
12. Gilbert J, Robinson T, Littlewood JM. Home intravenous antibiotic treatment in cystic fibrosis. Arch Dis Child 1988;63:512-7.
13. Donati MA, Guenette G, Auerbach H. Prospective controlled study of home and hospital therapy of cystic fibrosis pulmonary disease. J Pediatr 1987;111:28-33.
14. Martínez MA, Votoroubek W, Hoefle K, Lemen RJ. Efficiency of respiratory home care for cystic patients. Am Rev Respir Dis 1987;135:194A.
15. Pond MN, Newport M, Joanes D, Conway SP. Home versus hospital intravenous antibiotic therapy in the treatment of young adults with cystic fibrosis. Eur Resp J 1994;7:1640-4.
16. Strandvik B, Hjelte L, Malmborg AS, Widen B. Home intravenous antibiotic treatment of patients with cystic fibrosis. Acta Paediatr 1992;81: 340-4.
17. Wolter JM, Bowler SD, Nolan PJ, McCormack JG. Home intravenous therapy in cystic fibrosis: a prospective randomized trial examining clinical, quality of life and cost aspects. Eur Respir J 1997;10:896-900.
18. Riethmueller J, Busch A, Damm V, Ziebach R, Stern M. Home and hospital antibiotic treatment prove similarly effective in cystic fibrosis. Infection 2002;30:387-91.
19. Muzenberger P, Levin S. Home parenteral antibiotic therapy for patients with cystic fibrosis. Hosp Pharm 1993;28:20-8.
20. Rahman A, Spencer D. Totally implantable vascular access devices for cystic fibrosis. Cochrane Database Syst Rev 2003;CD004111.
21. Kuzemko JA. Home treatment of pulmonary infection in cystic fibrosis. Chest 1988;94162S-5S.
22. Van Aalderen WMC, Mannes GPM, Bosma ES, Roorda RJ, Heymans HSA. Home care in cystic fibrosis. Eur Respir J 1995;8:172-5.
23. Wai AO, Frighetto L, Marra CA, Chan E, Jewesson PJ. Cost analysis of an adult outpatient parenteral antibiotic therapy (OPAT) programme. A Canadian teaching hospital and Ministry of Health perspective. Pharmacoeconomics 2000;18:451-7.